News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
695,728 Results
Type
Article (39530)
Company Profile (247)
Press Release (655951)
Section
Business (204094)
Career Advice (2007)
Deals (35412)
Drug Delivery (94)
Drug Development (81001)
Employer Resources (172)
FDA (16149)
Job Trends (14842)
News (345025)
Policy (32495)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2546)
Accelerated approval (2)
Adcomms (20)
Allergies (80)
Alliances (49362)
ALS (81)
Alzheimer's disease (1345)
Antibody-drug conjugate (ADC) (107)
Approvals (16150)
Artificial intelligence (225)
Autoimmune disease (13)
Automation (14)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (18)
Biosimilars (100)
Biotechnology (175)
Bladder cancer (56)
Brain cancer (24)
Breast cancer (245)
Cancer (1957)
Cardiovascular disease (147)
Career advice (1673)
Career pathing (29)
CAR-T (139)
Cell therapy (392)
Cervical cancer (17)
Clinical research (65643)
Collaboration (757)
Compensation (446)
Complete response letters (18)
COVID-19 (2580)
CRISPR (34)
C-suite (203)
Cystic fibrosis (98)
Data (1896)
Decentralized trials (2)
Denatured (16)
Depression (36)
Diabetes (241)
Diagnostics (6326)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (109)
Drug pricing (95)
Drug shortages (25)
Duchenne muscular dystrophy (84)
Earnings (86119)
Editorial (31)
Employer branding (21)
Employer resources (146)
Events (111568)
Executive appointments (626)
FDA (17234)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (681)
Gene editing (94)
Generative AI (18)
Gene therapy (270)
GLP-1 (677)
Government (4377)
Grass and pollen (4)
Guidances (48)
Healthcare (18802)
Huntington's disease (22)
IgA nephropathy (21)
Immunology and inflammation (101)
Indications (26)
Infectious disease (2708)
Inflammatory bowel disease (131)
Inflation Reduction Act (8)
Influenza (46)
Intellectual property (83)
Interviews (311)
IPO (16484)
IRA (40)
Job creations (3628)
Job search strategy (1422)
Kidney cancer (9)
Labor market (34)
Layoffs (449)
Leadership (15)
Legal (7899)
Liver cancer (70)
Lung cancer (287)
Lymphoma (129)
Machine learning (2)
Management (58)
Manufacturing (264)
MASH (59)
Medical device (13312)
Medtech (13317)
Mergers & acquisitions (19391)
Metabolic disorders (619)
Multiple sclerosis (67)
NASH (16)
Neurodegenerative disease (75)
Neuropsychiatric disorders (24)
Neuroscience (1805)
NextGen: Class of 2025 (6511)
Non-profit (4476)
Northern California (2384)
Now hiring (37)
Obesity (336)
Opinion (201)
Ovarian cancer (71)
Pain (75)
Pancreatic cancer (76)
Parkinson's disease (130)
Partnered (18)
Patents (199)
Patient recruitment (93)
Peanut (46)
People (57045)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20443)
Phase II (28908)
Phase III (21541)
Pipeline (959)
Podcasts (44)
Policy (107)
Postmarket research (2563)
Preclinical (8648)
Press Release (64)
Prostate cancer (91)
Psychedelics (30)
Radiopharmaceuticals (243)
Rare diseases (350)
Real estate (5900)
Recruiting (65)
Regulatory (22107)
Reports (46)
Research institute (2316)
Resumes & cover letters (349)
Rett syndrome (3)
RNA editing (2)
RSV (37)
Schizophrenia (61)
Series A (120)
Series B (77)
Service/supplier (11)
Sickle cell disease (49)
Southern California (2058)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3572)
State (2)
Stomach cancer (12)
Supply chain (59)
The Weekly (25)
United States (20830)
Vaccines (652)
Venture capitalists (37)
Webinars (12)
Weight loss (224)
Women's health (33)
Worklife (15)
Date
Today (14)
Last 7 days (564)
Last 30 days (2524)
Last 365 days (33476)
2025 (7624)
2024 (35220)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (717)
Alabama (49)
Alaska (7)
Arizona (223)
Arkansas (13)
Asia (37681)
Australia (6160)
California (5436)
Canada (1853)
China (465)
Colorado (244)
Connecticut (256)
Delaware (123)
Europe (80789)
Florida (809)
Georgia (190)
Idaho (57)
Illinois (488)
India (23)
Indiana (288)
Iowa (9)
Japan (138)
Kansas (100)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (822)
Massachusetts (4085)
Michigan (208)
Minnesota (366)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (62)
New Jersey (1545)
New Mexico (28)
New York (1560)
North Carolina (908)
North Dakota (7)
Northern California (2384)
Ohio (190)
Oklahoma (14)
Oregon (33)
Pennsylvania (1237)
Puerto Rico (9)
Rhode Island (26)
South America (1094)
South Carolina (18)
South Dakota (1)
Southern California (2058)
Tennessee (92)
Texas (809)
Utah (163)
Virginia (127)
Washington D.C. (57)
Washington State (506)
West Virginia (3)
Wisconsin (48)
695,728 Results for "allakos inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Allakos Will Axe 75% of Workforce, Drop Hives Candidate
Following disappointing clinical trial results for AK006, Allakos will cut its workforce down to under 20 employees as it explores strategic alternatives.
January 27, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Allakos Provides Business Update and Reports Fourth Quarter 2024 Financial Results
March 13, 2025
·
6 min read
Business
Allakos Provides Business Update and Reports First Quarter 2024 Financial Results
Allakos Inc., a biotechnology company developing antibodies for the treatment of allergic, inflammatory and proliferative diseases, provided a business update and reported financial results for the first quarter ended March 31, 2024.
May 9, 2024
·
8 min read
Drug Development
Allakos Announces First Patient Dosed in Phase 1 Trial of AK006 in Chronic Spontaneous Urticaria
Allakos Inc. announced that the first patient with chronic spontaneous urticaria has been dosed in a randomized, double-blind, placebo-controlled Phase 1 trial of AK006.
May 28, 2024
·
5 min read
Press Releases
Allakos Announces Topline Results from its Phase 1 Trial of AK006 in Patients with Chronic Spontaneous Urticaria and Announces Restructuring
January 27, 2025
·
5 min read
Press Releases
Allakos Provides Business Update and Reports Third Quarter 2024 Financial Results
November 7, 2024
·
8 min read
Drug Development
Allakos Announces Positive Results from its Ongoing Phase 1 Trial of AK006 in Healthy Volunteers, with AK006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety Profile
Allakos Inc. (Nasdaq: ALLK), a biotechnology company developing AK006 for the treatment of mast cell-driven diseases, today announced positive results from the single and multiple ascending Phase 1 study of intravenous (IV) AK006 in healthy volunteers
June 25, 2024
·
6 min read
Biotech Bay
Allakos Announces a Restructuring to Focus on Development of AK006
Allakos Inc. today announced a restructuring to reduce costs and to focus on AK006 clinical development and additional preclinical programs. As a result, the Company’s cash runway is expected to extend into mid-2026.
January 16, 2024
·
8 min read
Biotech Bay
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition
Allakos Inc. (Nasdaq: ALLK), a clinical-stage biotechnology company developing therapeutics that target immunomodulatory receptors present on immune effector cells involved in allergy, inflammatory and proliferative diseases, today announced the publication of new scientific results in Allergy.
February 12, 2024
·
6 min read
Business
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antibodies for the treatment of allergic, inflammatory and proliferative diseases, today provided a business update and reported financial results for the fourth quarter and full year ended December 31, 2023.
March 14, 2024
·
9 min read
1 of 69,573
Next
